{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T22:25:46Z","timestamp":1794522346474,"version":"4.9.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750.2024-2-36"],"award-info":[{"award-number":["320.6750.2024-2-36"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.pnpbp.2025.111468","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T15:18:54Z","timestamp":1755011934000},"page":"111468","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Genetic and clinical factors associated with the metabolism of valproic acid in post-neurosurgery patients"],"prefix":"10.1016","volume":"141","author":[{"given":"Xinfeng","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongping","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiuhong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangshuang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiying","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2025.111468_bb0005","doi-asserted-by":"crossref","DOI":"10.1002\/wsbm.1417","article-title":"PharmGKB: a worldwide resource for pharmacogenomic information","volume":"10","author":"Barbarino","year":"2018","journal-title":"Wiley Interdiscip. Rev. Syst. Biol. Med."},{"key":"10.1016\/j.pnpbp.2025.111468_bb0010","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1609\/icwsm.v3i1.13937","article-title":"Gephi: an open source software for exploring and manipulating networks","author":"Bastian","year":"2009","journal-title":"Proc. Int. AAAI Conf. Web Soc. Media"},{"key":"10.1016\/j.pnpbp.2025.111468_bb0015","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/epi.13011","article-title":"Clinical significance of CYP 2C9-status guided valproic acid therapy in children","volume":"56","author":"B\u0171di","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.pnpbp.2025.111468_bb0020","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.aaz1776","article-title":"Gte The GTEx consortium atlas of genetic regulatory effects across human tissues","volume":"369","author":"Consortium","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2025.111468_bb0025","series-title":"Amitriptyline Therapy and CYP2D6 and CYP2C19 Genotype","author":"Dean","year":"2017"},{"key":"10.1016\/j.pnpbp.2025.111468_bb0030","doi-asserted-by":"crossref","first-page":"25","DOI":"10.64719\/pb.7073","article-title":"Pharmacokinetics, drug interactions, and tolerability of valproate","volume":"37","author":"DeVane","year":"2003","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.pnpbp.2025.111468_bb0035","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/FTD.0000000000000337","article-title":"Effects of UGT1A6 and GABRA1 on standardized valproic acid plasma concentrations and treatment effect in children with epilepsy in China","volume":"38","author":"Feng","year":"2016","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.pnpbp.2025.111468_bb0040","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.phrs.2006.11.001","article-title":"Gender differences in drug responses","volume":"55","author":"Franconi","year":"2007","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.pnpbp.2025.111468_bb0045","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/FPC.0b013e32835ea0b2","article-title":"Valproic acid pathway: pharmacokinetics and pharmacodynamics","volume":"23","author":"Ghodke-Puranik","year":"2013","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.pnpbp.2025.111468_bb0050","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2174\/1381612825666190329145428","article-title":"Valproic acid and the liver injury in patients with epilepsy: an update","volume":"25","author":"Guo","year":"2019","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.pnpbp.2025.111468_bb0055","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1177\/10600280211055508","article-title":"Valproic acid after neurosurgery induces elevated risk of liver injury: a prospective nested case-control study","volume":"56","author":"Guo","year":"2022","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.pnpbp.2025.111468_bb0060","doi-asserted-by":"crossref","first-page":"D891","DOI":"10.1093\/nar\/gkad1049","article-title":"Ensembl 2024","volume":"52","author":"Harrison","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.pnpbp.2025.111468_bb0065","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/obr.12358","article-title":"Why are there race\/ethnic differences in adult body mass index\u2013adiposity relationships? A quantitative critical review","volume":"17","author":"Heymsfield","year":"2016","journal-title":"Obes. Rev."},{"key":"10.1016\/j.pnpbp.2025.111468_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11060554","article-title":"The functionality of UDP-glucuronosyltransferase genetic variants and their association with drug responses and human diseases","volume":"11","author":"Jarrar","year":"2021","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.pnpbp.2025.111468_bb0075","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/toxsci\/kfl096","article-title":"Contribution of CYP2C9, CYP2A6, and CYP2B6 to valproic acid metabolism in hepatic microsomes from individuals with the CYP2C9* 1\/* 1 genotype","volume":"94","author":"Kiang","year":"2006","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.pnpbp.2025.111468_bb0080","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3349\/ymj.2014.55.1.232","article-title":"Comprehensive variant screening of the UGT gene family","volume":"55","author":"Kim","year":"2014","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.pnpbp.2025.111468_bb0085","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.24956.2","article-title":"gprofiler2--an R package for gene list functional enrichment analysis and namespace conversion toolset g: Profiler","volume":"9","author":"Kolberg","year":"2020","journal-title":"F1000Res"},{"key":"10.1016\/j.pnpbp.2025.111468_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v028.i05","article-title":"Building predictive models in R using the caret package","volume":"28","author":"Kuhn","year":"2008","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.pnpbp.2025.111468_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12091362","article-title":"Racial\/ethnic differences in the pharmacokinetics of antipsychotics: focusing on east Asians","volume":"12","author":"Lin","year":"2022","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.pnpbp.2025.111468_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106876","article-title":"Joint use of population pharmacokinetics and machine learning for prediction of valproic acid plasma concentration in elderly epileptic patients","volume":"201","author":"Ma","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.pnpbp.2025.111468_bb0105","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/15563650802178136","article-title":"Valproic acid poisoning: an evidence-based consensus guideline for out-of-hospital management","volume":"46","author":"Manoguerra","year":"2008","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.pnpbp.2025.111468_bb0110","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1067\/mcp.2000.104736","article-title":"Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation","volume":"67","author":"Manyike","year":"2000","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.pnpbp.2025.111468_bb0115","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.seizure.2017.07.005","article-title":"Genetic polymorphisms and valproic acid plasma concentration in children with epilepsy on valproic acid monotherapy","volume":"51","author":"Mei","year":"2017","journal-title":"Seizure"},{"key":"10.1016\/j.pnpbp.2025.111468_bb0120","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/bcp.13510","article-title":"A systematic review of population pharmacokinetics of valproic acid","volume":"84","author":"Methaneethorn","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.pnpbp.2025.111468_bb0125","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.clinbiochem.2013.06.012","article-title":"Adverse drug reactions induced by valproic acid","volume":"46","author":"Nanau","year":"2013","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.pnpbp.2025.111468_bb0130","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ygeno.2003.09.008","article-title":"Ethnic differences in the linkage disequilibrium and distribution of single-nucleotide polymorphisms in 35 candidate genes for cardiovascular diseases","volume":"83","author":"Ng","year":"2004","journal-title":"Genomics"},{"key":"10.1016\/j.pnpbp.2025.111468_bb0135","unstructured":"Rahman, M., Awosika, A.O., Nguyen, H., n.d. Valproic Acid. [Updated 2024 Mar 19]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK559112\/, [Updated 2024 Mar 19]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK559112\/."},{"key":"10.1016\/j.pnpbp.2025.111468_bb0140","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3390\/biomedicines12051036","article-title":"Ethnic aspects of Valproic acid P-oxidation","volume":"12","author":"Shnayder","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.pnpbp.2025.111468_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112021","article-title":"Hidden pharmacological activities of valproic acid: a new insight","volume":"142","author":"Singh","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.pnpbp.2025.111468_bb0150","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.clineuro.2010.01.002","article-title":"The influence of cytochrome oxidase CYP2A6, CYP2B6, and CYP2C9 polymorphisms on the plasma concentrations of valproic acid in epileptic patients","volume":"112","author":"Tan","year":"2010","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.pnpbp.2025.111468_bb0155","doi-asserted-by":"crossref","first-page":"5002","DOI":"10.1158\/1078-0432.CCR-09-0494","article-title":"Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes","volume":"15","author":"Voso","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.pnpbp.2025.111468_bb0160","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/cpt.2350","article-title":"An evidence-based framework for evaluating pharmacogenomics knowledge for personalized medicine","volume":"110","author":"Whirl-Carrillo","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.pnpbp.2025.111468_bb0165","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2217\/pgs-2022-0156","article-title":"Effects of UGT1A, CYP2C9\/19 and ABAT polymorphisms on plasma concentration of valproic acid in Chinese epilepsy patients","volume":"24","author":"Zheng","year":"2023","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.pnpbp.2025.111468_bb0170","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/jhg.2017.91","article-title":"The pharmacogenomics of valproic acid","volume":"62","author":"Zhu","year":"2017","journal-title":"J. Hum. Genet."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584625002222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584625002222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T19:31:14Z","timestamp":1765913474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584625002222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":34,"alternative-id":["S0278584625002222"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111468","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic and clinical factors associated with the metabolism of valproic acid in post-neurosurgery patients","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111468","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111468"}}